kato GF, Lopes RN, Jaguar GC, Silva AP, Alves FA. Evaluation of socket healing in patients undergoing bisphosphonate
therapy: Experience of a single
Institution. Med Oral Patol Oral Cir Bucal. 2013 Jul 1;18 (4):e650-6.
doi:10.4317/medoral.18787
http://dx.doi.org/doi:10.4317/medoral.18787
|
1. Fleisch H. Development of bisphosphonates. Breast Cancer Res. 2002;4:30-4. |
|
|
|
|
|
2. Devogelaer JP. Treatment of bone diseases
with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol.
2000;12:331-35. |
|
|
|
|
|
3. Dalle Carbonare
L, Zanatta M, Gasparetto
A, Valenti MT. Safety and tolerability of zoledronic acid and other bisphosphonates
in osteoporosis management. Drug Healthc Patient Saf. 2010;2:121-37. |
|
|
|
|
|
4. Coleman RE, McCloskey EV. Bisphosphonates
in oncology. Bone. 2011;49:71-6. |
|
|
|
|
|
5. Tanvetyanon T, Stiff PJ. Management of
the adverse effects associated with intravenous bisphosphonates.
Ann Oncol.
2006;17:897-907. |
|
|
|
|
|
6. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra
B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis
of the jaws. J Oral Maxillofac
Surg. 2009;67;2-12. |
|
|
|
|
|
7. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related
osteonecrosis of the jaw: so many hypotheses, so
few data. J Oral Maxillofac
Surg. 2009;67:61-70. |
|
|
|
|
|
8. Yoneda T, Hagino
H, Sugimoto T, Ohta H, Takahashi S, Soen S, et al. Bisphosphonate-related
osteonecrosis of the jaw: position paper from the
Allied Task Force Committee of Japanese Society for Bone and Mineral
Research, Japan Osteoporosis Society, Japanese Society of Periodontology,
Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of
Oral and Maxillofacial Surgeons. J Bone Miner Metab.
2010;28:365-83. |
|
|
|
|
|
9. Urade
M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, et al. Nationwide Survey for Bisphosphonate-Related Osteonecrosis
of the Jaws in Japan. J Oral Maxillofac Surg. 2011;69:364-71. |
|
|
|
|
|
10. Bocanegra-Pérez MS,
Vicente-Barrero M, Sosa-Henríquez M, Rodríguez-Bocanegra E, Limi-ana-Ca-al JM,
López-Márquez A, et al. Bone metabolism and clinical study of 44 patients
with bisphosphonate-related osteonecrosis
of the jaws. Med Oral Patol Oral Cir
Bucal. 2012;17:e948-55. |
|
|
|
|
|
11. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis:
risk factors, prediction of risk using serum CTX testing, prevention, and
treatment. J Oral Maxillofac
Surg. 2007;65:2397-410. |
|
|
|
|
|
12. Bedogni A, Saia G, Bettini
G, Tronchet A, Totola A, Bedogni G, et al. Long-term outcomes of surgical
resection of the jaws in cancer patients with bisphosphonate-related
osteonecrosis. Oral
Oncol. 2011;47:420-4. |
|
|
|
|
|
13. Junquera L, Gallego
L, Cuesta P, Pelaz A, de Vicente JC. Clinical
experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30:390-5. |
|
|
|
|
|
14. Regev E, Lustmann
J, Nashef R. Atraumatic
teeth extraction in bisphosphonate-treated
patients. J Oral Maxillofac
Surg. 2008;66:1157-61. |
|
|
|
|
|
15. Lodi G, Sardella A, Salis
A, Federica D, Tarozzi M, Carrassi
A. Tooth extraction in patients taking intravenous bisphosphonates:
a preventive protocol and case series. J
Oral Maxillofac Surg.
2010;68:107-110. |
|
|
|
|
|
16. Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, et al.
Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth Extraction.
J Oral Maxillofac
Surg. 2010;68:797-804. |
|
|
|
|
|
17. Scoletta M, Arduino
P, Pol R, Arata V, Silvestri S, Chiecchio A, et
al. Initial Experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report. J Oral Maxillofac Surg. 2011;69:456-462. |
|
|
|
|
|
18. Ferlito S, Puzzo
S, Liardo C. Preventive protocol for tooth
extractions in patients treated with zoledronate: a
case series. J Oral Maxillofac
Surg. 2011;69:1-4. |
|
|
|
|
|
19. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis
of the jaw caused by soft tissue toxicity?. Bone. 2007;41:318-20. |
|
|
|
|
|
20. Roelofs AJ, Thompson K, Gordon S, Rogers
MJ. Molecular mechanisms of action of bisphosphonates:
current status. Clin Cancer Res. 2008;12:6222-30. |
|
|
|
|
|
21. Allen MR, Kubek DJ, Burr DB, Ruggiero
SL, Chu TM. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos
Int. 2011;22:693-702. |
|
|
|
|
|
22. Bagan
JV, Jiménez Y, Hernández S, Murillo J, Díaz JM, Poveda
R, et al. Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis:
a comparative study. Med Oral Patol Oral Cir
Bucal. 2009;14:e616-9. |
|
|
|
|
|
23. Cornish J, Bava U, Callon
KE, Bai J, Naot D, Reid
IR. Bone-bound bisphosphonate inhibits growth of
adjacent non-bone cells. Bone. 2011;49:710-6. |
|
|
|
|
|
24. Bascones-Martínez
A, Mu-oz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in periodontal disease: Basic mechanisms. Med Oral Patol Oral Cir Bucal.
2009;14:e680-5. |
|